User menu

Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway.

Bibliographic reference Mace, Brian E ; Wang, Haichen ; Lynch, John R ; Moss, Jason ; Sullivan, Patrick ; et. al. Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway.. In: Neurological research, Vol. 29, no. 3, p. 243-50 (2007)
Permanent URL
  1. Mahley R., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, 10.1126/science.3283935
  2. Laskowitz Daniel T., Sheng Huaxin, Bart Robert D., Joyner Kelly A., Roses Allen D., Warner David S., Apolipoprotein E-Deficient Mice Have Increased Susceptibility To Focal Cerebral Ischemia : , 10.1097/00004647-199707000-00005
  3. Sheng H., Laskowitz D. T., Mackensen G. B., Kudo M., Pearlstein R. D., Warner D. S., Iadecola C., Apolipoprotein E Deficiency Worsens Outcome From Global Cerebral Ischemia in the Mouse   Editorial Comment, 10.1161/01.str.30.5.1118
  4. Chen Y, Lomnitski L, Michaelson D.M, Shohami E, Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury, 10.1016/s0306-4522(97)00007-9
  5. Lynch John R., Pineda Jose A., Morgan Duncan, Zhang Lin, Warner David S., Benveniste Helen, Laskowitz Daniel T., Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema, 10.1002/ana.10098
  6. Weisgraber Karl H., Apolipoprotein E: Structure-Function Relationships, Lipoproteins, Apolipoproteins, and Lipases (1994) ISBN:9780120342457 p.249-302, 10.1016/s0065-3233(08)60642-7
  7. Corder E., Saunders A., Strittmatter W., Schmechel D., Gaskell P., Small G., Roses A., Haines J., Pericak-Vance M., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, 10.1126/science.8346443
  8. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease., 10.1073/pnas.90.5.1977
  9. Alberts MarkJ., Graffagnino Carmen, McClenny Cheryl, DeLong David, Strittmatter Warren, Saunders AnnM., Roses AllenD., ApoE genotype and survival from intracerebral haemorrhage, 10.1016/s0140-6736(95)91411-0
  10. Sorbi Sandro, Nacmias Benedetta, Piacentini Silvia, Repice Anna, Latorraca Stefania, Forleo Paolo, Amaducci Luigi, ApoE as a prognostic factor for post–traumatic coma, 10.1038/nm0995-852
  11. Teasdale Graham M, Nicoll James AR, Murray Gordon, Fiddes Matilda, Association of apolipoprotein E polymorphism with outcome after head injury, 10.1016/s0140-6736(97)04318-3
  12. Tardiff Barbara E, Newman Mark F, Saunders Ann M, Strittmatter Warren J, Blumenthal James A, White William D, Croughwell Narda D, Davis R.Duane, Roses Allen D, Reves Joseph G, Preliminary Report of a Genetic Basis for Cognitive Decline After Cardiac Operations 11The members of the Neurologic Outcome Research Group of the Duke Heart Center are listed in Appendix A., 10.1016/s0003-4975(97)00757-1
  13. Sheng Huaxin, Laskowitz Daniel T., Bennett Ellen, Schmechel Donald E., Bart Robert D., Saunders Ann M., Pearlstein Robert D., Roses Allen D., Warner David S., Apolipoprotein E Isoform-Specific Differences in Outcome from Focal Ischemia in Transgenic Mice, 10.1097/00004647-199804000-00003
  14. Sabo T, Lomnitski L, Nyska A, Beni S, Maronpot R.R, Shohami E, Roses A.D, Michaelson D.M, Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities, 10.1016/s0306-4522(00)00438-3
  15. Horsburgh K, Eur J Neurosci, 12, 4309 (2000)
  16. Barger Steven W., Harmon Ashley D., Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E, 10.1038/42257
  17. Laskowitz D.T, Goel S, Bennett E.R, Matthew W.D, Apolipoprotein E suppresses glial cell secretion of TNFα, 10.1016/s0165-5728(97)00021-0
  18. Laskowitz D.T., Thekdi A.D., Thekdi S.D., Han S.K.D., Myers J.K., Pizzo S.V., Bennett E.R., Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides, 10.1006/exnr.2001.7541
  19. Lynch John R., Tang Wen, Wang Haichen, Vitek Michael P., Bennett Ellen R., Sullivan Patrick M., Warner David S., Laskowitz Daniel T., APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response, 10.1074/jbc.m306923200
  20. Lynch J.R., Morgan D., Mance J., Matthew W.D., Laskowitz D.T., Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response, 10.1016/s0165-5728(00)00459-8
  21. Lynch John R., Wang Haichen, Mace Brian, Leinenweber Stephen, Warner David S., Bennett Ellen R., Vitek Michael P., McKenna Suzanne, Laskowitz Daniel T., A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury, 10.1016/j.expneurol.2004.11.014
  22. Hixson JE, I Lipid Res, 31, 545 (1990)
  23. Uyttenhove C., Simpson R. J., Van Snick J., Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity., 10.1073/pnas.85.18.6934
  24. HAMM ROBERT J., PIKE BRIAN R., O'DELL DIANNE M., LYETH BRUCE G., JENKINS LARRY W., The Rotarod Test: An Evaluation of Its Effectiveness in Assessing Motor Deficits Following Traumatic Brain Injury, 10.1089/neu.1994.11.187
  25. Patkai Juliana, Mesples Bettina, Dommergues Marie-Aliette, Fromont Gaëlle, Thornton Elisabeth M, Renauld Jean-Christophe, Evrard Philippe, Gressens Pierre, Deleterious Effects of IL-9–Activated Mast Cells and Neuroprotection by Antihistamine Drugs in the Developing Mouse Brain, 10.1203/00006450-200108000-00010
  26. Friedman G., Froom P., Sazbon L., Grinblatt I., Shochina M., Tsenter J., Babaey S., Yehuda A. B., Groswasser Z., Apolipoprotein E- 4 genotype predicts a poor outcome in survivors of traumatic brain injury, 10.1212/wnl.52.2.244
  27. Jordan B. D., Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing, 10.1001/jama.278.2.136
  28. Kutner Kenneth C., Erlanger David M., Tsai Julia, Jordan Barry, Relkin Norman R., Lower Cognitive Performance of Older Football Players Possessing Apolipoprotein E ε4 : , 10.1227/00006123-200009000-00026
  29. McCarron M. O., Weir C. J., Muir K. W., Hoffmann K. L., Graffagnino C., Nicoll J. A. R., Lees K. R., Alberts M. J., Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage, 10.1034/j.1600-0404.2003.01365.x
  30. Schiefermeier M., Kollegger H., Madl C., Schwarz C., Holzer M., Kofler J., Sterz F., Apolipoprotein E Polymorphism : Survival and Neurological Outcome After Cardiopulmonary Resuscitation, 10.1161/01.str.31.9.2068
  31. Schmidt Silke, Barcellos Lisa F., DeSombre Karen, Rimmler Jacqueline B., Lincoln Robin R., Bucher Patricia, Saunders Ann M., Lai Eric, Martin Eden R., Vance Jeffery M., Oksenberg Jorge R., Hauser Stephen L., Pericak-Vance Margaret A., Haines Jonathan L., Multiple Sclerosis Genetics Group, Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple Sclerosis, 10.1086/339269
  32. Demoulin Jean-Baptiste, Renauld Jean-Christophe, Interleukin 9 and its Receptor: An Overview of Structure and Function, 10.3109/08830189809043001
  33. Dines Kevin C., Powell Henry C., Mast Cell Interactions with the Nervous System : Relationship to Mechanisms of Disease, 10.1097/00005072-199706000-00001
  34. Sztriha László, Joó Ferenc, Szerdahelyi Péter, Histamine H2-receptors participate in the formation of brain edema induced by kainic acid in rat thalamus, 10.1016/0304-3940(87)90545-3
  35. Breitner J, Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs, 10.1016/0197-4580(95)00049-k
  36. Bart Robert D., Sheng Huaxin, Laskowitz Daniel T., Pearlstein Robert D., Warner David S., Regional CBF in apolipoprotein E-deficient and wild type mice during focal cerebral ischemia : , 10.1097/00001756-199808030-00035
  37. Knouff Christopher, Hinsdale Myron E., Mezdour Hafid, Altenburg Michael K., Watanabe Masahiko, Quarfordt Steven H., Sullivan Patrick M., Maeda Nobuyo, Apo E structure determines VLDL clearance and atherosclerosis risk in mice, 10.1172/jci6172
  38. Anthony J. C., Breitner J. C. S., Zandi P. P., Meyer M. R., Jurasova I., Norton M. C., Stone S. V., Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study, 10.1212/wnl.54.11.2066